We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01516983
First Posted: January 25, 2012
Last Update Posted: February 17, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Betta Pharmaceuticals Co.,Ltd.
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)